Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC). Iqirvo ...
One evening in the early 1970s, Michael Pachovas and a few friends wheeled themselves to a curb in Berkeley, Calif., poured cement into the form of a crude ramp, and rolled off into the night. 1 For ...
U.S. stocks ended slightly mixed on Thursday after paring deeper losses, as diplomatic signals from the Middle East helped calm markets rattled earlier by U.S. President Donald Trump's threats of ...
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results